Email Address / User Name:
:Remember Login

Register Here!

Our Services

Naked Short List

by Date

by Exchange

Our Press Releases

SEC & Other Articles

Symbol :

Listed 3 Consecutive Market Days. On List as of 01/23/2012 Through 01/26/2012

Current Quote*

Last: $6.380
Volume: 5,004,034

As Of: 2014-04-24 23:04:58 ET
*Quotes delayed by 20min.

Mannkind Corp (NASDAQ:MNKD)
Industry: Healthcare

MannKind Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic products for diabetes and cancer in the United States. Its lead product candidate includes AFREZZA inhalation powder, an insulin that is in late-stage clinical investigation for the treatment of adults with type 1 or type 2 diabetes for the control of hyperglycemia. The company also develops MedTone and Dreamboat inhaler devices. MannKind Corporation was founded in 1991 and is headquartered in Valencia, California.

Realtime Data

BuyIns.Net Releases for Symbol MNKD

3 Month

6 Month

1 Year